mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.01 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.01 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.01 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.01 |